Erwinase 10 000 U powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

erwinase 10 000 u powder for solution for injection/infusion

porton biopharma limited - crisantaspase - powder for solution for injection/infusion - 10,000 unit(s) - asparaginase

Enrylaze European Union - English - EMA (European Medicines Agency)

enrylaze

jazz pharmaceuticals ireland limited - crisantaspase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

ERWINASE Crisantaspase 10,000 IU/3mL powder for  injection/infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

erwinase crisantaspase 10,000 iu/3ml powder for injection/infusion vial

ppd australia pty ltd - crisantaspase, quantity: 10000 u - injection, powder for - excipient ingredients: sodium chloride; glucose monohydrate; acetic acid; sodium hydroxide - erwinase is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (all) who have developed hypersensitivity to pegylated asparaginase obtained from e. coli.

RYLAZE SOLUTION Canada - English - Health Canada

rylaze solution

jazz pharmaceuticals ireland limited - crisantaspase - solution - 10mg - crisantaspase 10mg

Erwinase 10,000 Units. Powder for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

erwinase 10,000 units. powder for solution for injection

jazz pharmaceuticals france sas - cristanspase - powder for solution for injection - 10000  international unit(s) - other antineoplastic agents; asparaginase

Erwinase 10000 U inj./inf. sol. (pwdr.) i.v./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

erwinase 10000 u inj./inf. sol. (pwdr.) i.v./i.m. vial

porton biopharma ltd. - crisantaspase 10000 iu - powder for solution for injection/infusion - asparaginase

Glibenclamide 2.5mg Tablets United Kingdom - English - myHealthbox

glibenclamide 2.5mg tablets

wockhardt uk ltd - glibenclamide bp - tablets - 2.5 mg - it is a hypoglycaemic agent indicated in the treatment of non-insulin dependent diabetes in patients who respond inadequately to dietary measures alone